LUMIBIRD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.55 EUR | -0.40% |
|
-2.33% | +3.04% |
| May. 23 | Lumibird: strategic plan confirms objectives | CF |
| May. 03 | Lumibird launches product for dry eyes | CF |
| Sales 2024 * | 224M 241M | Sales 2025 * | 244M 264M | Capitalization | 277M 299M |
|---|---|---|---|---|---|
| Net income 2024 * | 15M 16.2M | Net income 2025 * | 20M 21.6M | EV / Sales 2024 * | 1.56 x |
| Net Debt 2024 * | 72.75M 78.57M | Net Debt 2025 * | 53.45M 57.73M | EV / Sales 2025 * | 1.35 x |
| P/E ratio 2024 * |
18.7
x | P/E ratio 2025 * |
14.1
x | Employees | 989 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 40.5% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| 1 day | -0.40% | ||
| 1 week | -2.33% | ||
| Current month | -2.33% | ||
| 1 month | -5.28% | ||
| 3 months | -9.06% | ||
| 6 months | +2.03% | ||
| Current year | +3.04% |
1 week
12.35
13.00
1 month
12.3513.65
Current year
10.4015.48
1 year
10.4015.60
3 years
10.4024.35
5 years
5.4024.35
10 years
5.4024.35
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 16-11-17 | |
Sonia Rutnam
DFI | Director of Finance/CFO | - | 22-11-30 |
| Director of Finance/CFO | - | 18-09-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 61 | 16-11-17 | |
| Director/Board Member | - | 16-04-04 | |
| Director/Board Member | - | 16-11-17 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-07 | 12.55 | -0.40% | 3,042 |
| 24-06-06 | 12.6 | -1.56% | 2,453 |
| 24-06-05 | 12.8 | -0.39% | 3,152 |
| 24-06-04 | 12.85 | 0.00% | 1,223 |
| 24-06-03 | 12.85 | 0.00% | 7,831 |
Real-time Euronext Paris, June 07, 2024 at 11:35 am EDT
More quotes
LUMIBIRD figure parmi les plus grands spécialistes mondiaux du laser. Fort de 50 années d'expérience et maîtrisant les technologies de laser à solides, de diodes laser et de laser à fibres, LUMIBIRD conçoit, fabrique et distribue des lasers haute performance à usages scientifiques (laboratoires de recherche et universités), industriels (production, défense/spatial, capteurs Lidar) et médical (ophtalmologie).
Calendar
2024-07-21
- Q2 2024 Sales and Revenue Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
12.55
EUR
Average target price
17.75
EUR
Spread / Average Target
+41.43%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +3.04% | 300M | |
| +9.48% | 222B | |
| +13.72% | 195B | |
| +23.79% | 148B | |
| +33.39% | 113B | |
| +4.75% | 66.45B | |
| +15.59% | 53.11B | |
| +3.16% | 50.03B | |
| -4.35% | 38.8B | |
| -1.27% | 34.85B |
- Stock Market
- Equities
- LBIRD Stock
